McKinsey Settles Opioid Crisis Charges for $650 Million

Consulting firm McKinsey has agreed to pay $650 million to settle charges related to its role in the US opioid crisis, where it allegedly conspired with Purdue Pharma to misbrand prescription drugs. The settlement includes a deferred prosecution agreement, requiring McKinsey to reform its practices. This follows previous settlements totaling nearly $1 billion over similar allegations. The opioid crisis has led to nearly 100,000 overdose deaths annually in the US.